Current guidelines recommend use of one or more long-acting inhaled bronchodilators for patients with moderate, severe, or very severe COPD. However, the initial choice of long-acting inhaled ...

This study highlights the benefits of anti-inflammatory inhalers in asthma management, showing reduced complications and ...

There are many types of asthma inhalers. They differ in whether they're used for quick relief or long-term control, what type ...

Symbicort is a combination inhaler used to control asthma and to maintain airflow in people with chronic obstructive ...

If an inhaled steroid does not help or does not relieve your symptoms enough, current guidelines from the National Heart, Lung, and Blood Institute recommend adding a long-acting bronchodilator ...

Conclusion: Tiotropium appears to be at least as effective as currently available alternatives in the treatment of patients with COPD who require daily bronchodilator treatment. Its simplified ...

Patients included those inadequately controlled with bronchodilators alone ... [as needed or regularly scheduled] or long-acting), theophylline, inhaled cromolyn or nedocromil sodium, leukotriene ...

Patients were permitted to use respiratory medications (including short-acting and long-acting beta-agonists, inhaled and systemic ... is a once-daily maintenance bronchodilator and should not ...

Immediate treatments include using short-acting bronchodilators (inhalers) for relief from acute symptoms. Antihistamines may ...

Opens in a new tab or window BOSTON -- Inhaled ... or short-acting beta-agonists (SABA) for asthma treatment were associated with reduced risks of severe exacerbations compared with bronchodilator ...

Results: In 39% of cases, short-acting inhaled Beta2-agonists are neither prescribed nor advised. In 68% short course of oral corticosteroids are not resorted to. Combination of long-acting ...